| Engineering vascularized tissue RK Jain, P Au, J Tam, DG Duda, D Fukumura Nature biotechnology 23 (7), 821-823, 2005 | 1002 | 2005 |
| Creation of long-lasting blood vessels N Koike, D Fukumura, O Gralla, P Au, JS Schechner, RK Jain Nature 428 (6979), 138-139, 2004 | 855 | 2004 |
| Bone marrow–derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature P Au, J Tam, D Fukumura, RK Jain Blood, The Journal of the American Society of Hematology 111 (9), 4551-4558, 2008 | 672 | 2008 |
| Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels P Au, LM Daheron, DG Duda, KS Cohen, JA Tyrrell, RM Lanning, ... Blood, The Journal of the American Society of Hematology 111 (3), 1302-1305, 2008 | 410 | 2008 |
| Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo ZZ Wang, P Au, T Chen, Y Shao, LM Daheron, H Bai, M Arzigian, ... Nature biotechnology 25 (3), 317-318, 2007 | 380 | 2007 |
| Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells R Samuel, L Daheron, S Liao, T Vardam, WS Kamoun, A Batista, ... Proceedings of the National Academy of Sciences 110 (31), 12774-12779, 2013 | 183 | 2013 |
| Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as … DG Duda, KS Cohen, E di Tomaso, P Au, RJ Klein, DT Scadden, ... Journal of Clinical Oncology 24 (9), 1449-1453, 2006 | 152 | 2006 |
| Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis G Cheng, S Liao, H Kit Wong, DA Lacorre, E Di Tomaso, P Au, ... Blood, The Journal of the American Society of Hematology 118 (17), 4740-4749, 2011 | 141 | 2011 |
| Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases E Chung, H Yamashita, P Au, BA Tannous, D Fukumura, RK Jain PloS one 4 (12), e8316, 2009 | 129 | 2009 |
| Gene therapy for cancer: regulatory considerations for approval SR Husain, J Han, P Au, K Shannon, RK Puri Cancer gene therapy 22 (12), 554-563, 2015 | 127 | 2015 |
| An FDA perspective on preclinical development of cell-based regenerative medicine products AM Bailey, M Mendicino, P Au Nature biotechnology 32 (8), 721-723, 2014 | 99 | 2014 |
| Mouse embryonic fibroblasts exhibit extensive developmental and phenotypic diversity PK Singhal, S Sassi, L Lan, P Au, SC Halvorsen, D Fukumura, RK Jain, ... Proceedings of the National Academy of Sciences 113 (1), 122-127, 2016 | 81 | 2016 |
| Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo P Au, J Tam, DG Duda, PC Lin, LL Munn, D Fukumura, RK Jain The American journal of pathology 175 (1), 294-302, 2009 | 56 | 2009 |
| FDA oversight of cell therapy clinical trials P Au, DA Hursh, A Lim, MC Moos Jr, SS Oh, BS Schneider, CM Witten Science translational medicine 4 (149), 149fs31-149fs31, 2012 | 45 | 2012 |
| Small blood vessel engineering P Au, J Tam, D Fukumura, RK Jain Tissue Engineering, 183-195, 2007 | 36 | 2007 |
| Translation of regenerative medicine products into the clinic in the United States: FDA perspective MH Lee, P Au, J Hyde, CG Johnson, M Heidaran, S Karandish, L Boxer, ... Translational regenerative medicine, 49-74, 2015 | 11 | 2015 |
| Translational Regenerative Medicine MH Lee, P Au, J Hyde, CG Johnson, M Heidaran, S Karandish, L Boxer, ... | 2 | 2015 |
| Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells (vol 110, pg 12774, 2013) R Samuel, L Daheron, S Liao, T Vardam, WS Kamoun, A Batista, ... PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF …, 2014 | | 2014 |
| Offering Guidance for Translation P Au, AM Bailey Science Translational Medicine 5 (180), 180ec63-180ec63, 2013 | | 2013 |
| Regulatory considerations of stem and progenitor cell-based products: US Food and Drug Administration DW Fink, SR Bauer, P Au, CC Haudenschild, MH Lee, BK McCright Progenitor and Stem Cell Technologies and Therapies, 147-168, 2012 | | 2012 |
